Altogether, this study brings the proof of concept that an IVM-based immunomodulatory therapy improves the clinical condition of SARS-CoV-2-infected hamsters, and in clinical trials, it alleviates symptoms of COVID-19 in humans and possibly limits post-COVID-19 syndrome (also known as long COVID) via an anti-inflammatory action.
I am undergoing a brutal cancelation and moral assassination attempt at my university for defending early treatment. Early treatment is effective and denying it today is causing death and suffering.
Dr. Vladimir Zelenko talks with author John Leake about treating his patients for Covid-19 and then sharing his insight with the White House. In spite of (or because of) President Trump’s initial embrace of Dr. Zelenko’s treatment protocol, government agencies such as the NIH and FDA first dismissed it, and then prevented public access to its key ingredient, hydroxychloroquine. This deliberate suppression of a life saving medication led to the preventable deaths of hundreds of thousands of Americans.
The data from the vaccine trials must be recalculated under the lens that some of the serious adverse events (SAEs) should be treated as COVID-19 cases.
There may not be any vaccine efficacy in the data at all if some of the post-vaccination deaths are due to vaccine-induced COVID-19. It could even be the case that the mortality efficacy goes negative. My implied lives saved calculations put this easily in the realm of possibility. The only way to know is for authorities to organize and compile the data. And while a risk analysis is certainly due after more than six months of hundreds of millions of doses delivered, there is little indication authorities have bothered with the process. That’s more than a bit unsettling.
We continue to delve extensively into the COVID-19 data with esteemed statistician, Mathew Crawford. In this episode, we take a closer look at the use of early treatment and its success. Mathew has been researching the data from Dr. Brian Tyson, who has successfully treated over 6000 patients who contracted COVID throughout the pandemic. It is my great honor to have Dr. Tyson here on this episode to not only discuss the data, but also the strategies that he has been using throughout the pandemic.
The Roman/Hernandez meta-analysis comes at a politically contentious moment. Their language and behavior appear political. Their work is error-laden, takes research out of its true context, uses numbers that don’t seem to come from the actual studies, chooses papers testing ivermectin under the least favorable circumstances, gives unexplained and inappropriate weights to the small amount of data that stands as outliers to the bigger picture, and still drives a conclusion of “don’t use this” from a massive average mortality reduction that did not quite reach statistical significance. At the same time the authors consistently complain about the “low quality of evidence” represented by the studies they do and do not include, nearly all of which I would describe as produced by higher quality scientists who can at least tally numbers correctly.
Those who design the trials and control the data also control the outcome. So this system of industry-led trials needs to be put to an end.
The death rate from COVID-19 is dramatically low at United Memorial Medical Center in Houston, TX compared to other hospitals across the nation and the world. Despite Dr. Joseph Varon’s popularity on TV, news personalities avoid questions of why he’s having success treating his patients. As it turns out, he’s using drugs the WHO and CDC recommend against.
Dr. Risch gives a succinct history of the politics of hydroxychloroquine and other useful existing medicines in the USA, which has had global effect, as many countries look to the USA for guidance. Corruption and manipulation from behind the scenes around the world are brought to the surface for scrutiny.
For months, India’s national authorities have authorized ivermectin as a regimen to be included targeting COVID-19 yet this authorization was then removed due in part to both internal and external political pressure. Now the world’s fourth most populous nation’s regulatory authority has authorised ivermectin’s use in a major breakthrough for the drug’s role in the COVID-19 pandemic.
Oxford University is going to investigate the effectiveness of ivermectin as a COVID-19 treatment. Emeritus Professor Robert Clancy, an immunologist at the University of Newcastle, tells Paul Turton that he believes they’ll find the drug useful, and that it will become part of our coronavirus response.
Source: Rounding The Earth Author: Mathew Crawford Since sometime last summer, I’ve paid (increasing) attention to much of the rapidly growing body of evidence that ivermectin (IVM)
Pointing out the drug’s safety, this German physician suggested that where ivermectin (Driponin in Germany) is in use, the incidence of COVID-19 goes down.
Large reductions in Covid-19 deaths are possible using ivermectin.
Using ivermectin early may reduce the numbers progressing to severe disease.
Ivermectin is low cost.
The results not only provide a structural basis for the anti-SARS-CoV-2 activity of HCQ, but also renders HCQ to be the first known drug capable of targeting LLPS.
Dr Patrick Phillips MD regarding Covid-19 Treatment… “Seeing what’s happened with the Ontario Science Table, not recommending Ivermectin, even recommending against Vitamin D, which I think is unthinkable, because the harm is none. This is a natural substance and they’re telling us NOT to give this to these patients despite mortality benefit. I know there is something going wrong and I knew I needed to speak out no matter what the college does to my license.”
The authors concluded based on this extensive review that ivermectin actually reduced the risk of death compared with no ivermectin (average risk ratio 0.38, 95% CI 0.19-0.73; n = 2438; I2 = 49%; moderate-certainty evidence).
Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.
Reporter Ivory Hecker says reporting on hydroxychloroquine was censored at her station, the local Fox affiliate in Houston.
The SOLIDARITY and RECOVERY protocols look prima facie like staged sabotage.I drew a picture to make the point: The WHO could not have plausibly chosen a less optimal treatment protocol.
Source: Rounding The Earth Author: Mathew Crawford Fifty years ago today, the New York Times began publication of the Pentagon Papers, informing the public about how a government-engineered
“For science to work, you have to have an open exchange of ideas,” Bhattacharya said of the censorship. “If you’re going to make an argument that something is misinformation, you should provide an actual argument. You can’t just take it down and say, ‘Oh, it’s misinformation’ without actually giving a reason.
In absolute honesty, I don’t think vaccines are even necessary. Why are they not necessary? Well that’s because there are at least four or five safe and effective medicines and their presence has been suppressed and hidden from the public, so they’re not really necessary.
During the first wave, the primary antiviral used was HCQ, and during the second wave (after Facebook censored his account where he was communicating with others in a large nation) they shifted to ivermectin due to HCQ controversies. Similarly to the way Dr. Brian Tyson attacked COVID-19 with an early multi-drug regimen, numerous other medicines, including aspirin, were used. Of Dr. Shah’s 8,000 or so patients, only 5 succumbed to COVID-19. This is notably similar to the results of Dr. Didier Raoult.
“We found that when the cumulative doses of two drugs, HCQ and AZM, were above a certain level, patients had a survival rate 2.9 times the other patients,” the authors of the study noted.
Ivermectin is on the WHO’s list of essential medicines and has a high safety profile with more than 3.7 billion doses having been distributed in more than 30 years.
This is pulled straight from the same playbook as the propaganda against HCQ. Even if you’re not sure that one or both of these medicines is effective despite uniformly positive results when applied as early treatment, you should at least recognize the pattern, scratch your head, and question whether there is…maybe…just possibly some perverse incentive like power or profit from vaccines driving this absurdity.
Source: India Today Author: Prabhash K Dutta Hydroxychloroquine, the malaria drug touted as a magical Covid-19 cure by former US President Donald Trump last year,
There are so many ways to attack this virus, so we’ll move forward with an argument that SARS-CoV-2 is far easier to handle than its public image suggests.
In a letter dated the 23rd of April, 2021, four Guest Editors publicly resigned from the journal Frontiers in Pharmacology. Professor Maria Cristina Albertini, Professor Piero Sestili, Dr. Robert Malone, and Dr. Howard Haimes stepped down in protest over executive decisions not to publish two papers showing positive results of various agents in protecting against or treating COVID-19.
Bret, Pierre, Heather, and a large number of internet pundits make a great case that suppression of ivermectin is a large, gross, and inhumane crime. However, this is not the “crime of the century”. The crime of the century is far larger, or rather more systemic.
In a new study, Smith and three other medical experts prove what he and this show have been telling you for more than a year that hydroxychloroquine can save lives. Smith’s landmark study followed 255 COVID patients who required intubation during the first two months of the pandemic, and it found that increased doses of coadministered, hydroxychloroquine and azithromycin were associated with a greater than 100% increase in survival.
Over 10,000 patients,a fatality rate more than 97% LOWER than France’s – an exceptional case for early treatment with a drug regimen including HCQ & AZM.
Most Covid studies have not considered days of therapy, cumulative dose, or weight-adjusted dosing. We found that when the cumulative doses of two drugs, HCQ and AZM, were above a certain level, patients had a survival rate 2.9 times the other patients. By using causal analysis and considering of weight-adjusted cumulative dose, we prove the combined therapy, >3 g HCQ and > 1g AZM greatly increases survival in Covid patients on IMV and that HCQ cumulative dose > 80 mg/kg works substantially better. These data do not yet apply to hospitalized patients not on IMV. Since those with higher doses of HCQ had higher doses of AZM, we cannot solely attribute the causal effect to HCQ/AZM combination therapy. However, it is likely AZM does contribute significantly to this increase in survival rate. Since higher dose HCQ/AZM therapy improves survival by nearly 200% in this population, the safety data are moot. However, given the data presented here, the studies reporting HCQ’s effect of QTc intervals need to be re-evaluated.
Just as fast as new cases materialized so has the decline thanks in part to a coordinated public health strategy that includes proactive testing, home visits, and medication kits that include ivermectin.
“The significant decline is a tremendous achievement in the fight against COVID-19 and further bolsters our appeal to undertake mass distribution of ivermectin to our people.”
With ivermectin now on the national Indian COVID-19 list of recommended treatments for COVID-19, a few states have gone to the next level and included the low-cost, generic drug approved throughout the world as a parasite fighter as a prophylactic targeting SARS-CoV-2, the virus behind COVID-19.
The kits distributed included ivermectin, aspirin and paracetamol. Between the end of November 2020 and the end of January 2021, more than 200,000 people tested positive for COVID, and of these, nearly 80,000 used the ivermectin kits. Results showed up to 76% reduction in hospitalization in the group that was taking ivermectin.
Zero patients in the ivermectin group that became hospitalized (as compared to 3 in the control group), the results were overall impressive.
McCullough walks through a thorough (if basic) coverage of many drugs and nutraceuticals that have been effectively used around the world—the best single such coverage seen packed into one video.
